COVID-19 ANtibody Responses in Cystic Fibrosis: CAR-CF (CAR-CF)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05745948 |
|
Recruitment Status :
Recruiting
First Posted : February 27, 2023
Last Update Posted : February 27, 2023
|
Sponsor:
Hospital Universitari Vall d'Hebron Research Institute
Collaborators:
Queen's University, Belfast
European Cystic Fibrosis Society - Clinical Trial Network
Cystic Fibrosis Foundation
Hospital Vall d'Hebron
Information provided by (Responsible Party):
Hospital Universitari Vall d'Hebron Research Institute
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | May 2025 |
| Estimated Study Completion Date : | May 2025 |